Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Subtherapeutic INR values associated with a switch to generic warfarin.

Hope KA, Havrda DE.

Ann Pharmacother. 2001 Feb;35(2):183-7.

PMID:
11215837
2.

Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials.

Pereira JA, Holbrook AM, Dolovich L, Goldsmith C, Thabane L, Douketis JD, Crowther MA, Bates SM, Ginsberg JS.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1188-93. Epub 2005 May 24.

PMID:
15914517
3.

Brand name versus generic warfarin: a systematic review of the literature.

Dentali F, Donadini MP, Clark N, Crowther MA, Garcia D, Hylek E, Witt DM, Ageno W; Warfarin Associated Research Projects and Other Endeavors (WARPED) Consortium..

Pharmacotherapy. 2011 Apr;31(4):386-93. doi: 10.1592/phco.31.4.386. Review.

PMID:
21449627
4.

Substitution of generic warfarin for Coumadin in an HMO setting.

Milligan PE, Banet GA, Waterman AD, Gatchel SK, Gage BF.

Ann Pharmacother. 2002 May;36(5):764-8.

PMID:
11978149
5.

Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.

Halkin H, Shapiro J, Kurnik D, Loebstein R, Shalev V, Kokia E.

Clin Pharmacol Ther. 2003 Sep;74(3):215-21.

PMID:
12966365
6.

Observational cohort study of switching warfarin sodium products in a managed care organization.

Swenson CN, Fundak G.

Am J Health Syst Pharm. 2000 Mar 1;57(5):452-5.

PMID:
10711525
7.

Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion program.

Witt DM, Tillman DJ, Evans CM, Plotkin TV, Sadler MA.

Pharmacotherapy. 2003 Mar;23(3):360-8.

PMID:
12627935
9.

Search for predictors of nontherapeutic INR results with warfarin therapy.

McGriff-Lee NJ, Csako G, Chen JT, Dang DK, Rosenfeld KG, Cannon RO, Macklin LR, Wesley RA; Anticoagulation Working Group..

Ann Pharmacother. 2005 Dec;39(12):1996-2002. Epub 2005 Nov 15.

PMID:
16288081
10.

Epistaxis associated with elevation of INR in a patient switched to generic warfarin.

Wagner JL, Dent LA.

Pharmacotherapy. 2000 Feb;20(2):240-3.

PMID:
10678304
11.

Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study.

Hellfritzsch M, Rathe J, Stage TB, Thirstrup S, Grove EL, Damkier P, PottegÄrd A.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):336-43. doi: 10.1002/pds.3942. Epub 2015 Dec 22.

PMID:
26696392
12.

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium..

Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.

PMID:
18657012
13.

Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis.

Ghate SR, Biskupiak JE, Ye X, Hagan M, Kwong WJ, Fox ES, Brixner DI.

Ann Pharmacother. 2011 Jun;45(6):701-12. doi: 10.1345/aph.1P593. Epub 2011 Jun 10.

PMID:
21666081
14.

A potential interaction between warfarin and atovaquone.

Hidalgo K, Lyles A, Dean SR.

Ann Pharmacother. 2011 Jan;45(1):e3. doi: 10.1345/aph.1P491. Epub 2010 Dec 28.

PMID:
21189363
15.

Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategies.

Moffett BS, Parham AL, Caudilla CD, Mott AR, Gurwitch KD.

Qual Saf Health Care. 2006 Aug;15(4):240-3.

16.

Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.

Kwong WJ, Kamat S, Fang C.

Ann Pharmacother. 2012 Dec;46(12):1609-16. doi: 10.1345/aph.1Q472. Epub 2012 Nov 13.

PMID:
23150608
17.

Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.

Wong YM, Quek YN, Tay JC, Chadachan V, Lee HK.

J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.

PMID:
21070296
18.

Correlation of the change in the International Normalized Ratio and decreasing the Coumadin dosage following total joint arthroplasty.

Rosenbaum CC, Woods SE, Hasselfeld KA.

Orthopedics. 2002 Dec;25(12):1359-63; discussion 1363.

PMID:
12502198
19.
20.

A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.

Dowd MB, Kippes KA, Witt DM, Delate T, Martinez K.

Thromb Res. 2012 Aug;130(2):152-6. doi: 10.1016/j.thromres.2011.12.017. Epub 2012 Jan 4.

PMID:
22221937

Supplemental Content

Support Center